4//SEC Filing
JOHNSON KENNETH ERLAND 4
Accession 0001867096-24-000169
CIK 0001867096other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:07 PM ET
Size
17.1 KB
Accession
0001867096-24-000169
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Tax Payment
Common Stock
2023-01-03$1.12/sh−12,400$13,888→ 425,736 total - Tax Payment
Common Stock
2023-01-31$1.24/sh−3,393$4,207→ 411,314 total - Tax Payment
Common Stock
2024-01-31$2.46/sh−15,131$37,222→ 373,036 total - Tax Payment
Common Stock
2022-01-29$2.11/sh−7,497$15,819→ 440,443 total - Tax Payment
Common Stock
2022-01-31$2.11/sh−2,307$4,868→ 438,136 total - Tax Payment
Common Stock
2023-01-29$1.26/sh−11,029$13,897→ 414,707 total - Tax Payment
Common Stock
2024-01-03$2.24/sh−12,400$27,776→ 398,914 total - Tax Payment
Common Stock
2024-01-29$2.66/sh−10,747$28,587→ 388,167 total
Footnotes (10)
- [F1]This transaction is being reported late due to administrative oversight.
- [F10]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.
- [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2022.
- [F3]These shares include 1,080 shares that were purchased on June 30, 2024 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
- [F4]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022.
- [F5]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023.
- [F6]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023.
- [F7]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.
- [F8]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.
- [F9]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001743774
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:07 PM ET
- Size
- 17.1 KB